We are live on ! Find out more
IBIO icon

iBio
IBIO

29 hedge funds and large institutions have $3.45M invested in iBio in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

248% more capital invested

Capital invested by funds: $990K → $3.45M (+$2.46M)

71% more call options, than puts

Call options by funds: $1.32M | Put options by funds: $773K

0.42% less ownership

Funds ownership: 1.09% → 0.67% (-0.42%)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

22% less funds holding

Funds holding: 37 → 29 (-8)

62% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 13

Holders
29
Holders Change
-8
Holders Change %
-21.62%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
7
Closed
13
Calls
$1.32M
Puts
$773K
Net Calls
+$551K
Net Calls Change
+$394K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$676K
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$113K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$56.2K
4
State Street
State Street
Massachusetts
+$22.1K
5
HighTower Advisors
HighTower Advisors
Illinois
+$15.4K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$631K
2
Renaissance Technologies
Renaissance Technologies
New York
-$404K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$173K
4
BlackRock
BlackRock
New York
-$169K
5
Millennium Management
Millennium Management
New York
-$31K
Name Holding Trade Value Shares
Change 		Change in
Stake
AAP
26
Arax Advisory Partners
Colorado
$75 – – –
WWP
27
WR Wealth Planners
Missouri
$17 – – –
SM
28
Sabby Management
Florida
– -$631K -24,523 Closed
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
– -$173K -6,742 Closed
Millennium Management
30
Millennium Management
New York
– -$31K -3,535 Closed
Two Sigma Investments
31
Two Sigma Investments
New York
– -$23.8K -2,673 Closed
WAM
32
Warberg Asset Management
Illinois
– -$22.2K -2,500 Closed
TSS
33
Two Sigma Securities
New York
– -$14.9K -1,679 Closed
T. Rowe Price Associates
34
T. Rowe Price Associates
Maryland
– -$6K -645 Closed
HF
35
HRT Financial
New York
– -$5K -601 Closed
Group One Trading
36
Group One Trading
Illinois
– -$10.3K -402 Closed
EDRH
37
Edmond de Rothschild Holding
Switzerland
– -$3.56K -400 Closed
Simplex Trading
38
Simplex Trading
Illinois
– -$6.05K -235 Closed
CA
39
Clearstead Advisors
Ohio
– -$13 -2 Closed
Bank of America
40
Bank of America
North Carolina
– -$6 -1 Closed
PNC Financial Services Group
41
PNC Financial Services Group
Pennsylvania
– -$4 – –
Carson Wealth (CWM LLC)
42
Carson Wealth (CWM LLC)
Nebraska
– +$26 +1 New
CG
43
Cutler Group
California
– +$257 +10 New
1
2

IBIO Hedge Fund Activity: Q1 2023 in Review

29 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q1 2023, worth a combined $3.45M — up 248% from $990K a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of IBIO and 5 opened new positions — a net loss of 8 holders — while 7 trimmed existing stakes and 6 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $676K. The largest seller was Sabby Management, exiting entirely with an estimated $631K sold.

  • 29 institutional investors held iBio (IBIO) as of Q1 2023, down from 37 in Q4 2022.
  • Funds reported $3.45M of iBio stock for Q1 2023, up 248% quarter-over-quarter.
  • 5 funds opened new iBio positions in Q1 2023 and 13 closed out, a net change of -8 holders.
  • The largest iBio buyer in Q1 2023 was Armistice Capital, an estimated $676K added.
  • The largest iBio seller in Q1 2023 was Sabby Management, an estimated $631K sold.

Based on aggregated 13F filings for Q1 2023.